Dosimetry of four heart-imaging radionuclides: 43K, 81Rb, 129Cs, and 201Ti

Area of Science:

• Nuclear Medicine
• Medical Physics
• Radiological Science

Background:

• Assessing the clinical utility of radionuclides for cardiac imaging requires understanding their radiation dosimetry.
• Accurate radiation dose estimates are crucial for patient safety in nuclear medicine procedures.

Purpose of the Study:

• To calculate and compare the radiation dosimetry for four key radionuclides: potassium-43 (43K), rubidium-81 (81Rb), cesium-129 (129Cs), and thallium-201 (201Tl).
• To determine the absorbed radiation dose to critical organs, including the heart, kidneys, liver, lungs, and testes, as well as the whole body for each radionuclide.

Main Methods:

• Radiation dosimetry estimates were computed using the Medical Internal Radiation Dose (MIRD) method.
• Distribution data from rat studies were extrapolated to humans, assuming similar organ concentration per mean whole-body concentration.
• Intravenous administration of radionuclides was considered for dose calculations.

Main Results:

• The calculated whole-body absorbed radiation doses per millicurie administered intravenously were: 81Rb (0.08 rads), 129Cs (0.17 rads), 201Tl (0.24 rads), and 43K (0.60 rads).
• Generally, the absorbed radiation doses to specific organs followed the same order as the whole-body doses across the four radionuclides.

Conclusions:

• Rubidium-81 (81Rb) exhibited the lowest whole-body radiation dose among the studied radionuclides.
• These dosimetry estimates provide valuable data for selecting the most suitable radionuclide for clinical heart imaging, balancing diagnostic efficacy with radiation safety.